Feedback / Questions
DC-15442 - DeepCure
https://www.prnewswire.com/news-releases/deepcure-announces-dc-15442-as-development-candidate-an-oral-stat6-inhibitor-with-100-in-vivo-inhibition-of-pstat6-and-comparable-efficacy-to-dupilumab-across-disease-models-302476939.html
Jun 10, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next